To address this question the SECURE-IBD registry was initiated and published already first results.57 This first publication included 525 cases from 33 countries and focused on the effects of corticosteroids, oral salicylates and TNF-blockers, whereas numbers of other immune modulatory IBD treatments were still low at the time of this initial publication. Here, TNF is linked to irritable bowel syndrome.